| CODE | PHR5636 | ||||||||||||
| TITLE | Advanced Experiential | ||||||||||||
| UM LEVEL | 05 - Postgraduate Modular Diploma or Degree Course | ||||||||||||
| MQF LEVEL | 7 | ||||||||||||
| ECTS CREDITS | 60 | ||||||||||||
| DEPARTMENT | Pharmacy | ||||||||||||
| DESCRIPTION | The study-unit presents three patient-focused practice experiences each of 6 weeks duration. The rotations will be undertaken in community practice, hospital and patient safety settings. Each student will be attached with a preceptor who will meet each student for one hour per week. Upon completion of the unit, individuals shall be highly qualified independent practitioners able to provide optimal patient-focused pharmaceutical judgements that account for quality, safe, effective and rationale use of medications. They can practice as integral members of an inter-disciplinary care team and be skilled at liaising with other healthcare professionals about medicinal products. These individuals will take a leadership role in quality and safety improvement initiatives with respect to medication use processes. Study-unit Aims: - To develop competent advanced clinical pharmacy specialists who are able to meet the needs of individual patients with complex pharmacotherapeutic requirements while acting as a fully integrated member of an interdisciplinary healthcare team; - To provide a hands-on exposure to a wide variety of complaints and illnesses and associated management in order to ensure broad foundational evidence-based pharmacotherapy knowledge and skills; - To provide experiences which develop skills in teaching other health care professionals and those in training to become healthcare professionals. Learning Outcomes: 1. Knowledge & Understanding: By the end of the study-unit the student will be able to: - Adopt problem-solving strategies in the management of a broad-range of disease states; - Determine from retrieved biomedical literature appropriate information to address requests for drug information; - Explain security and patient protections as related to the use of information technology to patient records; - Understand impact of different pharmacy procurement processes on medication-use processes; - Manage use of investigational medicinal products according to regulatory requirements and protocols. 2. Skills: By the end of the study-unit the student will be able to: - Identify opportunities for improvement of medication-use systems; - Design and implement quality improvement changes in medication-use systems; - Provide patients and health care professionals advice and information; - Document pharmaceutical processes including adverse drug reactions and medication errors; - Exercise leadership and practice management; - Demonstrate project management skills; - Function as a primary preceptor for students; - Use evidence-based literature to develop informed pharmaceutical assessment in drug use evaluation, patient therapy and population health risk. Main Text/s and any supplementary readings: Kouzes JM, Ponser BZ. The leadership challenge: How to make extraordinary things happen in organizations. 6th edition. Wiley; 2017. Kliethermes MA, Brown TR. Building a successful ambulatory care practice: Advancing patient care. USA: ASHP; 2019. Uselton JP, Kienle PC, Murdaugh LB. Meeting accreditation standards: A pharmacy preparation guide. USA: ASHP; 2020. White SJ, Boyer ST, Scott BE. Letters from leaders in pharmacy: Advice from pharmacy leadership academy graduates, faculty and mentors. USA: ASHP; 2020. |
||||||||||||
| ADDITIONAL NOTES | This study-unit is assessed on a Pass/Fail basis. | ||||||||||||
| STUDY-UNIT TYPE | Placement | ||||||||||||
| METHOD OF ASSESSMENT |
|
||||||||||||
| LECTURER/S | |||||||||||||
|
The University makes every effort to ensure that the published Courses Plans, Programmes of Study and Study-Unit information are complete and up-to-date at the time of publication. The University reserves the right to make changes in case errors are detected after publication.
The availability of optional units may be subject to timetabling constraints. Units not attracting a sufficient number of registrations may be withdrawn without notice. It should be noted that all the information in the description above applies to study-units available during the academic year 2025/6. It may be subject to change in subsequent years. |
|||||||||||||